BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23105704)

  • 21. Systematic review of laser therapy in xanthelasma palpebrarum.
    Nguyen AH; Vaudreuil AM; Huerter CJ
    Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis and clinical significance of xanthelasma palpebrarum.
    Bergman R
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):236-42. PubMed ID: 8288783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthelasma: An Update on Treatment Modalities.
    Laftah Z; Al-Niaimi F
    J Cutan Aesthet Surg; 2018; 11(1):1-6. PubMed ID: 29731585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of xanthelasma palpebrarum by upper eyelid skin flap incorporating blepharoplasty.
    Yang Y; Sun J; Xiong L; Li Q
    Aesthetic Plast Surg; 2013 Oct; 37(5):882-6. PubMed ID: 23943013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Xanthelasma Palpebrarum using Pulsed Dye Laser: Original Report on 14 Cases.
    Thajudheen CP; Jyothy K; Arul P
    J Cutan Aesthet Surg; 2019; 12(3):193-195. PubMed ID: 31619894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship Between Xanthelasma Palpebrarum and Hyperlipidemia.
    Wang KY; Hsu KC; Liu WC; Yang KC; Chen LW
    Ann Plast Surg; 2018 Feb; 80(2S Suppl 1):S84-S86. PubMed ID: 29424765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: A systematic review and meta-analysis.
    Chang HC; Sung CW; Lin MH
    J Am Acad Dermatol; 2020 Mar; 82(3):596-605. PubMed ID: 31499151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).
    Ozdöl S; Sahin S; Tokgözoğlu L
    Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
    Heng JK; Chua SH; Goh CL; Cheng S; Tan V; Tan WP
    J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic insight into putative causes of xanthelasma palpebrarum: a Mendelian randomization study.
    Hu W; Liu Y; Lian C; Lu H
    Front Immunol; 2024; 15():1347112. PubMed ID: 38601164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum.
    Mourad B; Elgarhy LH; Ellakkawy HA; Elmahdy N
    J Cosmet Dermatol; 2015 Sep; 14(3):209-15. PubMed ID: 26251333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral extensive xanthelasma palpebrarum.
    Tosti A; Varotti C; Tosti G; Giovannini A
    Cutis; 1988 Feb; 41(2):113-4. PubMed ID: 3345685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular profile of xanthelasma palpebrarum.
    Dey A; Aggarwal R; Dwivedi S
    Biomed Res Int; 2013; 2013():932863. PubMed ID: 23865074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum.
    Kim YG; Oh JW; Lee KC; Yoon SH
    Arch Craniofac Surg; 2022 Apr; 23(2):71-76. PubMed ID: 35526842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of intramuscular xanthelasma palpebrarum found during blepharoplasty.
    Chung YH; Kang SY; Choi WS
    Arch Craniofac Surg; 2018 Dec; 19(4):296-299. PubMed ID: 30613094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthelasma palpebrarum removed with Atmospheric Plasma technique: 11-year follow up.
    Scarano A; Inchingolo F; Scogna G; Leo L; Crisante A; Greco Lucchina A; Lorusso F
    J Biol Regul Homeost Agents; 2021; 35(2 Suppl. 1):181-185. PubMed ID: 34281315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
    Fusade T
    Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma.
    Ribera M; Pintó X; Argimon JM; Fiol C; Pujol R; Ferrándiz C
    Am J Med; 1995 Nov; 99(5):485-90. PubMed ID: 7485205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral and extensive xanthelasma palpebrarum in a young man.
    Depot MJ; Jakobiec FA; Dodick JM; Iwamoto T
    Ophthalmology; 1984 May; 91(5):522-7. PubMed ID: 6739054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xanthelasma palpebrarum: a review and current management principles.
    Rohrich RJ; Janis JE; Pownell PH
    Plast Reconstr Surg; 2002 Oct; 110(5):1310-4. PubMed ID: 12360073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.